During the past decade, AIM Trials conducted 20 clinical trials. In the 10-year time frame, 20 clinical trials started and 8 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 8 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "AIM Trials" #1 sponsor was "Pfizer" with 4 trials, followed by "H. Lundbeck A/S" with 3 trials sponsored, "Allergan" with 2 trials sponsored, "Biohaven Pharmaceuticals, Inc." with 2 trials sponsored and "ModernaTX, Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "AIM Trials" #1 collaborator was "Takeda" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "AIM Trials" are "Bipolar Disorder" (2 trials), "Chronic Gout" (2 trials), "Respiratory Syncytial Virus" (2 trials), "Acute Treatment of Migraine" (1 trials) and "Depression" (1 trials). Many other conditions were trialed in "AIM Trials" in a lesser frequency.

Most popular intervention types in "AIM Trials" are "Drug" (16 trials), "Other" (4 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "SEL-212A" (2 trials), "SEL-212B" (2 trials), "mRNA-1345" (2 trials) and "Androderm®" (1 trials). Other intervention names were less common.

The vast majority of trials in "AIM Trials" are 19 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "AIM Trials". undefined are not yet recruiting, 7 are recruiting, 3 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 5 completed trials in AIM Trials, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in AIM Trials, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".